BBSRC Portfolio Analyser
Award details
The development of antibodies specific for conformational isomers of recombinant ovine PrP and their evaluation as diagnostics tools
Reference
BSD17727
Principal Investigator / Supervisor
Professor Garry Whitelam
Co-Investigators /
Co-Supervisors
Professor Kevin Gough
,
Mr R Jackman
Institution
University of Leicester
Department
Biology
Funding type
Research
Value (£)
183,412
Status
Completed
Type
Research Grant
Start date
01/07/2002
End date
30/09/2005
Duration
39 months
Abstract
Currently, all TSE diagnostics are post mortem immunoassays applied to central nervous system (CNS) tissues and are able only to identify symptomatic animals, or in some cases those nearing clinical disease. The limitation of such tests is primarily one of analytical sensitivity inherent in the need for sample pretreatment involving digestion with protein kinase K or differential solubilisation in chaotropic agents to eliminate the normal cellular form of the prion protein (PrPc). These procedures significantly reduce the levels of the disease isoform (PrPsc) in the extract applied to the endpoint immunoassay and may also only target a percentage of the PrPsc present that is in an aggregated form. To extend the use of CNS as the analytical matrix in animals of earlier age and to apply immunoassays to lymphoreticular system tissues (post mortem) and body fluids (pre-mortem/live animal), destructive sample preparation systems must be eliminated by the development of immunoreagents capable of binding to PrPsc specifically in the presence of PrPc. This proposal seeks to produce such antibodies by phage display through the use of the beta-form of recombinant PrP. This beta-sheet rich conformation will be used as a pure panning target for the selection of binders from both naive phage display antibody libraries and from immune libraries created from rabbits immunised with the beta-form of PrP. Resultant soluble antibodies will be evaluated in a range of immunoassays including ELISA and immunoblots following their demonstration of specificity by immunoprecipitation of PrPsc. Appropriate immunoassays will then be applied to a range of clinical and pre-clinical tissues and body fluids from TSE infected animals.
Summary
unavailable
Committee
Closed Committee - Agri-food (AF)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
Biology Spongiform Encephalopathies - Diagnostics (BSD) [2000]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search